Hypnosis to improve comfort during transoesophageal echocardiography
Official title: Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography
Run by Fondation Hôpital Saint-Joseph · NCT07512830 · Data updated 2026-11-12
This trial will test whether conversational and brief hypnosis given by the cardiologist can make transoesophageal echocardiography easier and less uncomfortable for adults having the procedure with local anaesthetic.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Fondation Hôpital Saint-Joseph Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Paris, Île-de-France Region) |
| Status | Recruiting |
| Started | February 18, 2026 |
| Main results expected | October 15, 2028 |
| Study ends | December 15, 2028 |
| Registry record updated | April 6, 2026 |
| Trial ID | NCT07512830 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) who require transoesophageal echocardiography under local anaesthetic, are French‑speaking, insured, and able to give free verbal consent are ideal candidates.
✕Probably not a fit
Patients with contraindications to TOE, known major psychiatric illness or cognitive impairment, those who are non‑French speaking, pregnant or breastfeeding, or under legal guardianship are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants undergoing transoesophageal echocardiography (TOE) will receive a combined conversational hypnosis period during the pre‑procedure explanation and a short, deliberate hypnosis phase performed by the cardiologist in the exam room. Their tolerance of the examination and the time required for the procedure will be compared with patients who receive a standard pre‑exam interview by a cardiologist not trained in these techniques. The procedure is done under local anaesthetic and the trial excludes patients with major psychiatric or cognitive disorders, contraindications to TOE, or pregnancy. Outcomes focus on patient comfort and procedural efficiency rather than changes in cardiac diagnosis.
Why it matters
Potential benefit: If successful, this approach could reduce patient discomfort during TOE and lower the need for general anaesthesia or prolonged monitoring.
How similar studies have gone: Hypnosis has shown benefit for procedure‑related anxiety and pain in other medical settings, but using conversational hypnosis specifically during TOE is novel and not well documented.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient aged ≥ 18 years old * Patient requiring a transoesophageal ultrasound scan under local anaesthetic. * Patient affiliated to a health insurance scheme * French-speaking patient * Patient who has given their free, informed and express verbal consent Exclusion Criteria: Patient with a contraindication to transoesophageal ultrasound (significant radiation exposure to the chest, oesophageal pathology with risk of bleeding) * Patients with known schizophrenia or known psychiatric illness (documented in medical records) * Patients with known dementia or known cognitive impairment (documented in medical records) * Patients already included in an interventional research protocol * Patients under guardianship or curatorship * Patients deprived of their liberty * Patients under judicial protection * Pregnant or breastfeeding patients
Where it's running
-
Hôpital Paris Saint Joseph
Paris, Île-de-France Region, France Recruiting
Study contacts
- Principal investigator: Yoann MOEUF, medical doctor — Hospital Paris saint Joseph
- Study coordinator: Yoann MOEUF, medical doctor
- Email: ymoeuf@ghpsj.fr
- Phone: +33 01-44-12-62-44
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Platelets and plasma lipids as markers and targets in thrombosis
This study tests whether two lipid emulsion formulations change platelet clumping in healthy volunteers age 40 and up who do not have heart disease.
-
Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation
This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.
-
Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases
In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.
-
FES-Cycling With Blood Flow Restriction for SCI/D Patients
This study tests safe and feasible use of functional electrical stimulation cycling with blood flow restriction in adults with spinal cord injury to see if it can help reduce cardiometabolic risk.
-
Endothelial progenitor cell dysfunction and inflammation in heart and blood vessel problems of type 2 diabetes
This project will test whether endothelial progenitor cells from adults with type 2 diabetes — with or without cardiovascular complications — have signaling and inflammation-related defects and whether boosting eNOS in those cells improves their repair function.
-
Link between sleep problems found with a brief questionnaire and heart disease
This project tests whether a short questionnaire used during cardiology visits can quickly find sleep problems related to cardiovascular disease in adult cardiology patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.